The data obtained in the WB analysis corroborated the qRT-PCR data, demonstrating a canine CD20 overexpression in B-cell lymphoma samples and thus supporting the rationale of using the CD20 as a promising B-cell lymphoma immunotherapy target for the veterinary setting. The gene discussed is MS4A1; the disease is B-cell non-Hodgkin lymphoma.